E2F3 is a direct downstream target of HOXB9 and is overexpressed in endometrial carcinoma tissues, and E2F3 overexpression enhances endometrial carcinoma cell migration ability [45]. This evidence concerns the gene E2F3 and endometrial carcinoma.